Zheng X - Search Results

1

Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.

Xu Y, Li J, Wang J, Hu X, Ma H, Li P, Zheng X, Chen M. Xu Y, et al. Among authors: zheng x. Oncol Lett. 2018 Feb;15(2):2641-2650. doi: 10.3892/ol.2017.7601. Epub 2017 Dec 13. Oncol Lett. 2018. PMID: 29434986 Free PMC article.

2

Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Xu Y, et al. Among authors: zheng x. Oncol Lett. 2013 Jan;5(1):185-190. doi: 10.3892/ol.2012.1007. Epub 2012 Oct 30. Oncol Lett. 2013. PMID: 23255917 Free PMC article.

3

Positive expression of p53, c-erbB2 and MRP proteins is correlated with survival rates of NSCLC patients.

Xu Y, Wang L, Zheng X, Liu G, Wang Y, Lai X, Li J. Xu Y, et al. Among authors: zheng x. Mol Clin Oncol. 2013 May;1(3):487-492. doi: 10.3892/mco.2013.72. Epub 2013 Jan 24. Mol Clin Oncol. 2013. PMID: 24649197 Free PMC article.

4

Cerebellar, brainstem and spinal cord metastases from esophageal cancer following radiotherapy: A case report and literature review.

Zhang P, Feng W, Zheng X, Wang YZ, Shan GP. Zhang P, et al. Among authors: zheng x. Oncol Lett. 2014 Jul;8(1):253-257. doi: 10.3892/ol.2014.2130. Epub 2014 May 9. Oncol Lett. 2014. PMID: 24959256 Free PMC article.

5

A new receptor tyrosine kinase inhibitor, icotinib, for patients with lung adenocarcinoma cancer without indication for chemotherapy.

Zheng X, Liu G, Wang S, Zhang Y, Bao W, Deng D, Mao W, Fang M. Zheng X, et al. Oncol Lett. 2014 Oct;8(4):1563-1566. doi: 10.3892/ol.2014.2386. Epub 2014 Jul 28. Oncol Lett. 2014. PMID: 25202368 Free PMC article.

6

Metastatic brain tumors from small-cell esophageal cancer: clinical characteristics and outcome.

Feng W, Harada H, Zhang P, Mitsuya K, Zheng X, Yasui H, Nakasu Y, Chen M, Nishimura T. Feng W, et al. Among authors: zheng x. J Cancer Res Ther. 2014 Dec;10 Suppl:256-8. doi: 10.4103/0973-1482.151469. J Cancer Res Ther. 2014. PMID: 25693930 Free article.

7

Neuroimaging and clinical characteristics of brain metastases from esophageal carcinoma in Chinese patients.

Feng W, Zhang P, Zheng X, Shan G, Chen M, Mao W. Feng W, et al. Among authors: zheng x. J Cancer Res Ther. 2014 Dec;10 Suppl:296-303. doi: 10.4103/0973-1482.151536. J Cancer Res Ther. 2014. PMID: 25693939 Free article.

8

Incidence and treatment of brain metastasis in patients with esophageal carcinoma.

Feng W, Zhang P, Zheng X, Chen M, Mao WM. Feng W, et al. Among authors: zheng x. World J Gastroenterol. 2015 May 21;21(19):5805-12. doi: 10.3748/wjg.v21.i19.5805. World J Gastroenterol. 2015. PMID: 26019444 Free PMC article. Review.

9

The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.

Xu Y, Wang Z, Liu G, Zheng X, Wang Y, Feng W, Lai X, Zhou X, Li P, Ma H, Wang J, Hu X, Chen M. Xu Y, et al. Among authors: zheng x. J Cancer Res Ther. 2016 Oct;12(Supplement):82-88. doi: 10.4103/0973-1482.191640. J Cancer Res Ther. 2016. PMID: 27721262 Free article.

10

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.

Xu Y, Zheng X, Bai X, Li P, Ma H, Wang J, Hu X, Chen M. Xu Y, et al. Among authors: zheng x. Oncotarget. 2017 Jul 25;8(30):49084-49092. doi: 10.18632/oncotarget.17094. Oncotarget. 2017. PMID: 28467775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,271 results

Search Page

Filters